| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/15/2011 | CA2792411A1 Method for proliferating cardiomyocytes using micro-rna |
| 09/14/2011 | EP2365097A1 Nucleic acid probe-based assays for prokaryotic and eukaryotic organisms |
| 09/14/2011 | EP2365094A1 Antisense modulation of PTP1B expression |
| 09/14/2011 | EP2365081A2 13 Transmembrane protein expressed in prostate cancer |
| 09/14/2011 | EP2365077A1 iRNA agents targeting VEGF |
| 09/14/2011 | EP2365076A1 Artificial ubiquitous chromatin opening elements (ucoe) |
| 09/14/2011 | EP2365075A1 Method for inhibiting the expression of a target gene and medicine for treating a tumour illness |
| 09/14/2011 | EP2365004A2 Membrane associated tumor endothelium markers |
| 09/14/2011 | EP2364990A1 Modulators of pharmacological agents |
| 09/14/2011 | EP2364734A1 Multi-component biological transport systems |
| 09/14/2011 | EP2364719A1 Prevention and treatment of amyloidogenic diseases |
| 09/14/2011 | EP2364330A2 Multiblock copolymers |
| 09/14/2011 | EP1761635B1 Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 09/14/2011 | EP1541674B9 Primary cultured adipocytes for gene therapy |
| 09/14/2011 | EP1262555B1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/14/2011 | EP1237582B1 Methods for introducing genes into mammalian subjects |
| 09/14/2011 | EP1027440B2 Inhibitor protein of the wnt signal pathway |
| 09/14/2011 | CN102183655A New molecular marker CUEDC2 (CUE Domain Containing 2) protein for prognosis judgement in endocrine therapy of breast cancer |
| 09/14/2011 | CN102181480A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 09/14/2011 | CN102181457A Clostridium difficile exotoxin B amino-terminal gene sequence with optimized codon and nucleic vaccine of clostridium difficile exotoxin B |
| 09/14/2011 | CN102181446A siRNA capability of preventing influenza virus as well as expression vector and pharmaceutical composition of siRNA |
| 09/14/2011 | CN102181445A Interference small molecule RNA of targeted LIN28 gene and glioma proliferation resistant application thereof |
| 09/14/2011 | CN102181407A Recombinant adenovirus and dendritic cell modified by recombinant adenovirus and application of recombinant adenovirus and dendritic cell |
| 09/14/2011 | CN102181406A Recombinant adenovirus, dendritic cell (DC) modified by recombinant adenovirus and application of recombinant adenovirus and DC |
| 09/14/2011 | CN102180927A Method for obtaining influenza virus nucleic acid in influenza sample and special primer thereof |
| 09/14/2011 | CN102180924A L-ribo-LNA analogues |
| 09/14/2011 | CN102178960A Application of Tap73 gene to preparation of cancer stem cell chemosensitization medicine |
| 09/14/2011 | CN102178959A siRNA for inhibiting growth of pulmonary metastasis tumor and oligonucleotide composition and application thereof |
| 09/14/2011 | CN102178958A MBD2-mTEM fused DNA vaccine and preparation method and application thereof |
| 09/14/2011 | CN102178957A Respiratory tract homing siRNA atomizing nanometer drug delivery system and preparation method thereof |
| 09/14/2011 | CN102178953A Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| 09/14/2011 | CN102178948A Genetic engineering drug for treating and/or preventing cervical cancer |
| 09/14/2011 | CN102178947A Live vector vaccine for expressing peste des petits ruminants virus (PPRV) H gene and preparation method thereof |
| 09/14/2011 | CN102178929A Application of ancylostoma caninum anticoagulant peptide (AcAP) and recombinant thereof in preparation of thrombus dissolving medicaments |
| 09/14/2011 | CN102178927A Application of interferon-induced transmembrane protein 3 (IFITM 3) for preparing medicament against hepatitis B virus (HBV) infection |
| 09/14/2011 | CN102178690A Preparation method of EGS nucleic acid drug for resisting influenza virus |
| 09/14/2011 | CN101837134B Chronic myeloid leukemia DNA vaccine BCR/ABL-pIRES-SEA and preparation method and application thereof |
| 09/14/2011 | CN101481675B Anti-swine fever multi-epitope DNA vaccine, construction method and use |
| 09/14/2011 | CN101444628B Gene therapy medicine for remedying erectile dysfunction and medicine box thereof |
| 09/14/2011 | CN101423517B Gamma-carbolines derivates as well as preparation method and application thereof |
| 09/14/2011 | CN101186637B Method for inhibiting influenza virus infection and medicament thereof |
| 09/13/2011 | US8017764 Therapeutic uses of inhibitors of RTP801L |
| 09/13/2011 | US8017761 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 09/13/2011 | US8017760 Antisense modulation of PTP1B expression |
| 09/13/2011 | US8017753 Mycobacterial antigens expressed under low oxygen tension |
| 09/13/2011 | US8017749 Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
| 09/13/2011 | US8017742 Gene carrier |
| 09/13/2011 | US8017727 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 09/13/2011 | US8017595 Delivering therapeutic formulation containing N-sulphated-N,O-carboxymethylchitosan as a primary carrier across a membrane that has limited permeability for therapeutic agent |
| 09/13/2011 | US8017593 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
| 09/13/2011 | US8017591 Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals |
| 09/13/2011 | US8017590 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/13/2011 | US8017577 Lyophilizable and enhanced compacted nucleic acids |
| 09/13/2011 | US8017399 System and method for electroporating a sample |
| 09/13/2011 | US8017392 Hox11+, CD45− cells and methods of organ regeneration using the same |
| 09/13/2011 | US8017317 Equine herpes viruses (EHV) with immunomodulatory capacity; respiratory and neurological diseases |
| 09/13/2011 | US8017134 Recombinant toxin fragments |
| 09/13/2011 | US8017131 Light chain that cleaves a neurosecretory protein; an HN domain that translocates the light chain across an endosome membrane and a substance P targeting moiety; the HC domain is removed or modified to reduce the targeting of the modified Clostridial toxin to the neuromuscular junction |
| 09/13/2011 | CA2480276C Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 09/13/2011 | CA2465303C Compositions and methods for wt1 specific immunotherapy |
| 09/13/2011 | CA2271690C Methods for regulating angiogenesis |
| 09/13/2011 | CA2220964C Alphavirus rna replicon systems |
| 09/09/2011 | WO2011109823A1 Inhibitory rnas to rna binding proteins hnrnpa1, hnrnpa2 and ptb and uses thereof |
| 09/09/2011 | WO2011109642A1 Aptamers to 4-1bb and their use in treating diseases and disorders |
| 09/09/2011 | WO2011108955A1 Multi -targeting system comprising a nanocarrier, nucleic acid(s) and non-nucleic acid based drug(s) |
| 09/09/2011 | WO2011108711A1 Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor |
| 09/09/2011 | WO2011108624A1 Polymer of nitrogen-containing compound, method for producing same, and gene transfer agent |
| 09/09/2011 | WO2011107648A1 Dendrimers as non-viral vehicles for gene therapy |
| 09/09/2011 | WO2011107647A1 Dendrimers as non-viral vehicles for gene therapy |
| 09/09/2011 | WO2011106997A1 Novel 10-23 deoxyribozyme analogues and uses thereof |
| 09/09/2011 | WO2010093904A9 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
| 09/09/2011 | CA2808233A1 Aptamers to 4-1bb and their use in treating diseases and disorders |
| 09/08/2011 | US20110218332 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 09/08/2011 | US20110218229 SIRT1 Modulation of Adipogenesis and Adipose Function |
| 09/08/2011 | US20110218154 Histone deacetylases, and uses related thereto |
| 09/08/2011 | US20110217779 Compositions and Methods for Non-Targeted Activation of Endogenous Genes |
| 09/08/2011 | US20110217361 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 09/08/2011 | US20110217332 Chimpanzee Adenovirus Vaccine Carriers |
| 09/08/2011 | US20110217326 Method for diagnosing and/or treating tumor |
| 09/08/2011 | US20110217314 Methods and Compositions for Modulating Apoptosis |
| 09/08/2011 | US20110217272 Treatment of radiation injury using placental stem cells |
| 09/08/2011 | US20110217271 Treatment of diseases or disorders using placental stem cells |
| 09/08/2011 | US20110217270 Methods for treating tumors and cancerous tissues |
| 09/08/2011 | US20110217267 Gene therapy vectors and cytosine deaminases |
| 09/08/2011 | DE102010010288A1 Medicament, useful to prevent or treat e.g. ulcerative colitis, comprises polypeptide sequences of cysteine-rich protein 61 (CCN1) and/or cyclic arginine-glycine-aspartic acid peptide, or nucleic acid encoding polypeptide sequence of CCN1 |
| 09/07/2011 | EP2363493A1 Novel insertion sites in pox vectors |
| 09/07/2011 | EP2363487A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/07/2011 | EP2363483A2 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |
| 09/07/2011 | EP2363479A1 Oligoribonucucleotide for inhibiting the expression of a predefined gene |
| 09/07/2011 | EP2363478A1 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 09/07/2011 | EP2363472A1 Method for enhancing expression of recombinant protein |
| 09/07/2011 | EP2363468A1 Tumor antigen peptide and use thereof |
| 09/07/2011 | EP2363404A2 PSMA antibodies |
| 09/07/2011 | EP2363152A1 Cardiac arrhythmia treatment methods |
| 09/07/2011 | EP2363141A1 Compsition comprising two oligonucleotides linked directly at their 3'ends wherein at leat one oligonucleotide has an accessible 5'end and the compound further comprising IL-2 used for synergistically stimulating an immune response in a patient. |
| 09/07/2011 | EP2362909A2 Mammalian genes involved in infection |
| 09/07/2011 | EP2362908A1 Antibodies that specifically block the biological activity of a tumor antigen |
| 09/07/2011 | EP2164964B1 Dehydrated chitosan nanoparticles |
| 09/07/2011 | EP1874930B1 Use of a galectin-1-trageted rnai-based approach for the treatment of cancer |
| 09/07/2011 | CN1840204B Lentiviral vectors for the preparation of immunotherapeutical compositions |